{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:42:17Z","timestamp":1794440537682,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFC2304903"],"award-info":[{"award-number":["2022YFC2304903"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2305202"],"award-info":[{"award-number":["2022YFC2305202"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFC2304403"],"award-info":[{"award-number":["2022YFC2304403"]}]},{"name":"Science and Technology Program of Shijiazhuang","award":["231200103A"],"award-info":[{"award-number":["231200103A"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82173583"],"award-info":[{"award-number":["82173583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-04144-8","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:18:52Z","timestamp":1760516332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro comparison of the susceptibilities of the same drug resistance mutations to reverse-transcriptase inhibitors of subtype B and CRF01_AE HIV-1 strains"],"prefix":"10.1038","volume":"15","author":[{"given":"Hanping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuiling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"issue":"19","key":"4144_CR1","doi-asserted-by":"publisher","first-page":"9864","DOI":"10.1128\/JVI.00915-10","volume":"84","author":"ME Abram","year":"2010","unstructured":"Abram, M. E. et al. Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication. J. Virol. 84 (19), 9864\u20139878 (2010).","journal-title":"J. Virol."},{"issue":"8","key":"4144_CR2","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1128\/jvi.69.8.5087-5094.1995","volume":"69","author":"LM Mansky","year":"1995","unstructured":"Mansky, L. M. & Temin, H. M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69 (8), 5087\u20135094 (1995).","journal-title":"J. Virol."},{"issue":"10","key":"4144_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1097\/QAD.0b013e32835461b5","volume":"26","author":"T Ndung\u2019u","year":"2012","unstructured":"Ndung\u2019u, T. & Weiss, R. A. On HIV diversity. Aids 26 (10), 1255\u20131260 (2012).","journal-title":"Aids"},{"issue":"2","key":"4144_CR4","first-page":"10","volume":"95","author":"J Hemelaar","year":"2024","unstructured":"Hemelaar, J. et al. Country level diversity of the HIV-1 pandemic between 1990 and 2015. J. Virol. 95(2) 10\u20131128 (2020).","journal-title":"J. Virol."},{"issue":"48","key":"4144_CR5","first-page":"1257","volume":"6","author":"Dong","year":"2024","unstructured":"Dong et al. Vital surveillances: National and regional molecular epidemiology of HIV-1 China, 2004\u20132023. China CDC Wkly. 6 (48), 1257\u20131263 (2024).","journal-title":"China CDC Wkly."},{"key":"4144_CR6","unstructured":"Organization, W. H. HIV data and statistics. Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data-and-statistics (2024)."},{"issue":"1","key":"4144_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1186\/s12879-024-09251-x","volume":"24","author":"A Hashempour","year":"2024","unstructured":"Hashempour, A. et al. Predictors of antiretroviral treatment failure to the first line therapy: A cross-sectional study among Iranian HIV-positive adults. BMC Infect. Dis. 24 (1), 358 (2024).","journal-title":"BMC Infect. Dis."},{"key":"4144_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgar.2023.07.013","volume":"35","author":"DV Kapustin","year":"2023","unstructured":"Kapustin, D. V. et al. Patterns of HIV-1 drug resistance among HIV-infected patients receiving first-line antiretroviral therapy in Novosibirsk region, Russia. J. Glob. Antimicrob. Resist. 35, 1\u20135 (2023).","journal-title":"J. Glob. Antimicrob. Resist."},{"issue":"30","key":"4144_CR9","doi-asserted-by":"publisher","first-page":"664","DOI":"10.46234\/ccdcw2023.129","volume":"5","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. Changes in HIV-1 subtypes\/sub-subtypes, and transmitted drug resistance among ART-na\u00efve HIV-infected individuals\u2013China, 2004\u20132022. China CDC Wkly. 5 (30), 664\u2013671 (2023).","journal-title":"China CDC Wkly."},{"key":"4144_CR10","unstructured":"Organization, W. H. Treat all: Policy adoption and implementation status in countries. World Health Organization: (2017). Available from:https:\/\/iris.who.int\/handle\/10665\/258538."},{"issue":"9","key":"4144_CR11","doi-asserted-by":"publisher","first-page":"F9","DOI":"10.1097\/01.aids.0000232228.88511.0b","volume":"20","author":"BG Brenner","year":"2006","unstructured":"Brenner, B. G. et al. HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. Aids. 20(9), F9\u2013F13 (2006).","journal-title":"Aids"},{"issue":"10","key":"4144_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3390\/v15101990","volume":"15","author":"ME Cilento","year":"2022","unstructured":"Cilento, M. E. et al. HIV-1 resistance to Islatravir\/tenofovir combination therapy in wild-type or NRTI-resistant strains of diverse HIV-1 subtypes. Viruses 15(10), 1990 (2023).","journal-title":"Viruses"},{"issue":"9","key":"4144_CR13","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.3390\/v16091493","volume":"16","author":"A Huang","year":"2024","unstructured":"Reddy, N. et al. K103N, V106M and Y188L significantly reduce HIV-1 subtype C phenotypic susceptibility to doravirine. Viruses 16(9), 1493 (2024).","journal-title":"Viruses"},{"issue":"2","key":"4144_CR14","doi-asserted-by":"publisher","first-page":"ofv158","DOI":"10.1093\/ofid\/ofv158","volume":"3","author":"A Huang","year":"2016","unstructured":"Huang, A. et al. Global comparison of drug resistance mutations after first-line antiretroviral therapy across human immunodeficiency virus-1 subtypes. Open. Forum Infect. Dis. 3 (2), ofv158 (2016).","journal-title":"Open. Forum Infect. Dis."},{"key":"4144_CR15","volume-title":"The Molecular Epidemiological Study on HIV Prevalent in Shenzhen and Construction of Infectious Clone of Dominant Strainin in China","author":"D Jia","year":"2017","unstructured":"Jia, D. The Molecular Epidemiological Study on HIV Prevalent in Shenzhen and Construction of Infectious Clone of Dominant Strainin in China (Anhui Medical University, 2017)."},{"issue":"10","key":"4144_CR16","first-page":"1103","volume":"19","author":"MJ Lee","year":"2009","unstructured":"Lee, M. J. & Park, J. H. Pathway analysis in HEK 293T cells overexpressing HIV-1 Tat and nucleocapsid. J. Microbiol. Biotechnol. 19 (10), 1103\u20131108 (2009).","journal-title":"J. Microbiol. Biotechnol."},{"issue":"5","key":"4144_CR17","first-page":"439","volume":"14","author":"J Sun","year":"2008","unstructured":"Sun, J. et al. Detection of phenotypic drug-resistance of HIV-1 strains by TZM-bl cell lines in China. Chin. J. AIDS STD. 14 (5), 439\u2013449 (2008).","journal-title":"Chin. J. AIDS STD"},{"issue":"10","key":"4144_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nmeth.2641","volume":"10","author":"DJ Dickinson","year":"2013","unstructured":"Dickinson, D. J. et al. Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat. Methods. 10 (10), 1028\u20131034 (2013).","journal-title":"Nat. Methods"},{"key":"4144_CR19","first-page":"p8","volume":"4","author":"M Xu","year":"2014","unstructured":"Xu, M. et al. Clinical detection of HIV-1 drug resistance using a novel HIV-1 phenotypic resistance system. Virol. Sin. 4, p8 (2014).","journal-title":"Virol. Sin"},{"issue":"10","key":"4144_CR20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1089\/aid.2011.0142","volume":"28","author":"MM Santoro","year":"2012","unstructured":"Santoro, M. M. et al. Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy. AIDS Res. Hum. Retroviruses. 28 (10), 1285\u20131293 (2012).","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"17","key":"4144_CR21","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1128\/JVI.00859-09","volume":"83","author":"KA Delviks-Frankenberry","year":"2009","unstructured":"Delviks-Frankenberry, K. A. et al. Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3\u2019-azido-3\u2019-deoxythymidine. J. Virol. 83 (17), 8502\u20138513 (2009).","journal-title":"J. Virol."},{"issue":"14\u201315","key":"4144_CR22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.micinf.2010.08.003","volume":"12","author":"J Tanuma","year":"2010","unstructured":"Tanuma, J. et al. Impact of CRF01_AE-specific polymorphic mutations G335D and A371V in the connection subdomain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on susceptibility to nucleoside RT inhibitors. Microbes Infect. 12 (14\u201315), 1170\u20131177 (2010).","journal-title":"Microbes Infect."},{"issue":"12","key":"4144_CR23","doi-asserted-by":"publisher","first-page":"7184","DOI":"10.1128\/AAC.05069-14","volume":"59","author":"PL Boyer","year":"2015","unstructured":"Boyer, P. L. et al. Analysis of the Zidovudine resistance mutations T215Y, M41L, and L210W in HIV-1 reverse transcriptase. Antimicrob. Agents Chemother. 59 (12), 7184\u20137196 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"4144_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12879-020-4836-z","volume":"20","author":"S Li","year":"2020","unstructured":"Li, S. et al. The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains. BMC Infect. Dis. 20 (1), 123 (2020).","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"4144_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/aid.2015.0331","volume":"32","author":"EP Lam","year":"2016","unstructured":"Lam, E. P. et al. Antiretroviral resistance after First-Line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study. AIDS Res. Hum. Retroviruses. 32 (9), 841\u2013850 (2016).","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"7","key":"4144_CR26","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","volume":"5","author":"JA Johnson","year":"2008","unstructured":"Johnson, J. A. et al. Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-na\u00efve populations and associate with reduced treatment efficacy. PLoS Med. 5 (7), e158 (2008).","journal-title":"PLoS Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04144-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04144-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T08:18:55Z","timestamp":1760516335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04144-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4144"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04144-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35936"}}